Don't miss the opportunity to attend an evening with Alessandro Chiesi, the Chairman of Chiesi Farmaceutici SpA.
Chiesi is a global, research-driven biopharmaceutical company focused on developing innovative therapies for respiratory, neonatal, and rare diseases.
It operates in 31 countries through its global network of affiliates and has over 7,000 employees worldwide, with over €3 billion turnover.